drugset / Trial / NCT06370195

Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome

NCT06370195 ↗

Unknown 100 enrolled Babujinaya Cela
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized controlled study, including dysphagic patients with Parkinson's syndrome who were received in the department of rehabilitation medicine. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, Functional Oral Intake Scale, Drooling amount, depression are assessed.

Timeline

Start
2024-04
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 ml Other

Indications